tiprankstipranks
Trending News
More News >
Rapid Dose Therapeutics Corp (TSE:DOSE)
:DOSE
Canadian Market

Rapid Dose Therapeutics Corp (DOSE) Income Statement

Compare
8 Followers

Rapid Dose Therapeutics Corp Income Statement

Last quarter (Q3 2026), Rapid Dose Therapeutics Corp's total revenue was C$657.13K, a decrease of -1.71% from the same quarter last year. In Q3, Rapid Dose Therapeutics Corp's net income was C$-1.14M. See Rapid Dose Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
May 24May 23Nov 22Feb 21Feb 20
Total Revenue
C$ 2.09MC$ 1.02MC$ 718.30KC$ 755.20KC$ 101.50K
Gross Profit
C$ 1.18MC$ 563.41KC$ 372.40KC$ 699.85KC$ 37.34K
Operating Expenses
C$ -4.22MC$ 4.30MC$ 4.18MC$ 2.33MC$ 7.65M
Depreciation and Amortization
C$ 240.75KC$ 620.31KC$ 627.44KC$ 675.47KC$ 484.06K
EBITDA
C$ -3.93MC$ -3.02MC$ -2.92MC$ -987.00KC$ -7.37M
Operating Income
C$ 5.40MC$ -3.74MC$ -3.81MC$ -1.78MC$ -7.50M
Other Income/Expenses
C$ -10.81MC$ -568.00KC$ -1.61KC$ -28.04KC$ -351.00K
Pretax Income
C$ -5.40MC$ -4.31MC$ -3.81MC$ -1.80MC$ -7.96M
Net Income
C$ -5.40MC$ -4.31MC$ -3.81MC$ -1.80MC$ -7.96M
Per Share Metrics
Basic EPS
C$ -0.04C$ -0.04C$ -0.04C$ -0.02C$ -0.10
Diluted EPS
C$ -0.04C$ -0.04C$ -0.04C$ -0.02C$ -0.10
Weighted Average Shares Outstanding
124.57M 104.96M 103.42M 77.79M 76.09M
Weighted Average Shares Outstanding (Diluted)
124.57M 104.96M 103.42M 77.79M 76.09M
Currency in CAD

Rapid Dose Therapeutics Corp Earnings and Revenue History